Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinic System and Cognitive Aging
NCT03408574Phase 1Completed
- Sponsor
- The University of Vermont
- Start
- Oct 2016
- Primary completion
- Dec 2021
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of nicotine patch in cognitive aging (2 arms), sponsored by The University of Vermont. Primary endpoints: Age effects of nicotinic blockade and Age effects of nicotinic stimulation. Started Oct 2016; status: completed.
02
Drugs
nicotine patch
03
Conditions
cognitive aging
Beyond the preview
Go deeper on NCT03408574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03408574.